Open AccessStudy of CD4+, CD8+, and natural killer cells (CD16+, CD56+) in children with immune thrombocytopenic purpura
Author(s) -
Farida Hussein El-Rashedi,
Mahmoud A. ElHawy,
Mohamed A. Helwa,
Sameh Abdallah
Publication year - 2017
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2017.01.001
Subject(s) - thrombocytopenic purpura , cd16 , immunology , immune system , medicine , cd8 , cd3
To assess the percentage of CD4 + , CD8 + , and natural killer cells (CD16 + , CD56 + ) in children with immune thrombocytopenic purpura (ITP) at presentation and study their impact on disease chronicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom